Skip to content
Home/Companies/MedTech/Biomatlante

Biomatlante

MedTech·France·Exited 2019·Held 3yr
Entry
2016
Hold
3yr
Exit
2019

Who owns Biomatlante?

Biomatlante is a French MedTech company, now owned by Advanced Medical Solutions, which acquired it in 2019 from Seventure Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Seventure Partners
Investor
Seventure Partners
Quadrivium 1 Seed Fund · 2013 · VC

Key facts

HQFrance
SectorMedTech
Exit Type
Trade Sale
Buyer
Advanced Medical Solutions
Exit Year
2019

More from Quadrivium 1 Seed Fund

Other portfolio companies in the same fund.

Dashbook
Dashbook
Active
E-commerceFrance· 2022
Artifakt
Active
Business ServicesFrance· 2021
Fire1
Active
MedTechUK· 2021
Algoan
Algoan
Active
FintechFrance· 2020
Humedics
Humedics
Active
MedTechGermany· 2019
Acarix
Acarix
Active
MedTechDenmark· 2018

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Biomatlante?

Biomatlante is now owned by Advanced Medical Solutions, which acquired it in 2019 from Seventure Partners.

When did Advanced Medical Solutions acquire Biomatlante?

Advanced Medical Solutions acquired Biomatlante in 2019, buying from Seventure Partners.

Who did Biomatlante sell to?

Seventure Partners sold Biomatlante to Advanced Medical Solutions in 2019 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue